XAF1 promotes neuroblastoma tumor suppression and is required for KIF1B?-mediated apoptosis.

ABSTRACT: Neuroblastoma is an aggressive, relapse-prone childhood tumor of the sympathetic nervous system. Current treatment modalities do not fully exploit the genetic basis between the different molecular subtypes and little is known about the targets discovered in recent mutational and genetic studies. Neuroblastomas with poor prognosis are often characterized by 1p36 deletion, containing the kinesin gene KIF1B. Its beta isoform, KIF1B?, is required for NGF withdrawal-dependent apoptosis, mediated by the induction of XIAP-associated Factor 1 (XAF1). Here, we showed that XAF1 low expression correlates with poor survival and disease status. KIF1B? deletion results in loss of XAF1 expression, suggesting that XAF1 is indeed a downstream target of KIF1B?. XAF1 silencing protects from NGF withdrawal and from KIF1B?-mediated apoptosis. Overexpression of XAF1 impairs tumor progression whereas knockdown of XAF1 promotes tumor growth, suggesting that XAF1 may be a candidate tumor suppressor in neuroblastoma and its associated pathway may be important for developing future interventions.

SUBMITTER: Choo Z 

PROVIDER: S-EPMC5085151 | biostudies-literature | 2016 Jun

REPOSITORIES: biostudies-literature